| Ronald L Weitemier, | |
|
983 S Beneva Rd, Sarasota, FL 34232 | |
| (941) 365-5355 | |
| (941) 954-3310 |
| Full Name | Ronald L Weitemier |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 983 S Beneva Rd, Sarasota, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104935360 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | ARNP 2786422 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ronald L Weitemier, 4326 Oak View Dr, Sarasota, FL 34232 Ph: (941) 342-8719 | Ronald L Weitemier, 983 S Beneva Rd, Sarasota, FL 34232 Ph: (941) 365-5355 |
News Archive
Colorectal surgical patients are often discharged from the hospital with vague guidance on how to recognize complications, but researchers at the Michael DeBakey Veterans Administration (VA) Medical Center and Baylor College of Medicine, Houston, aim to change that scenario.
A new study lead by the Neuroscience Institute of Alicante reveals how manipulating the endocannabinoid system can modulate high levels of impulsivity. This is the main problem in psychiatric illnesses such a schizophrenia, bipolar disorder and substance abuse.
Womens News Network/Guardian Development Network examines a WHO/United Nations Human Settlements Programme report released last week that highlighted the health disparities affecting populations living in urban areas.
Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, today announced a strategic partnership between the company's contract research organization, Caliper Discovery Alliances & Services (CDAS), and Prestwick Chemical (Strasbourg, France) to provide customized outsourced medicinal chemistry and in vitro and in vivo preclinical biology programs for drug discovery research.
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the investigational anti-Xa intravenous anticoagulant otamixaban reduced by 27 to 42 percent the odds of the composite primary endpoint of death, myocardial infarction, urgent revascularization or rescue GPIIb/IIIa use in 4 out of the 5 otamixaban tested doses, versus standard UFH/eptifibatide combination in [non-ST] ACS patients suitable for invasive strategy.
› Verified 8 days ago
Mrs. Krista Marie Peverini, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3325 S Tamiami Trl, Sarasota, FL 34239 Phone: 941-552-3480 Fax: 941-552-3485 | |
Niki Gates, RN, MSN, CRNA, APRN Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1261 S Tamiami Trl, Sarasota, FL 34239 Phone: 941-366-2360 Fax: 941-366-3123 | |
Dana Keough, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1700 S Tamiami Trl, Sarasota, FL 34239 Phone: 941-917-9000 | |
Mr. Keith Alan Ramey, BSN CRNA ARNP Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 983 S Beneva Rd, Sarasota, FL 34232 Phone: 941-954-3310 | |
Mr. Arnold Castillo Navarro, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1261 S Tamiami Trl, Sarasota, FL 34239 Phone: 941-366-1164 Fax: 941-366-3123 | |
Liudmila Aizina, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1261 S Tamiami Trl, Sarasota, FL 34239 Phone: 941-366-2360 | |
Beth A Beres, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1261 S Tamiami Trl, Sarasota, FL 34239 Phone: 941-366-2360 Fax: 941-366-3123 |